EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.
暂无分享,去创建一个
F Berrino | P Roazzi | F. Berrino | G. Gatta | G. Hédelin | J. Faivre | T. Möller | M. Sant | R. Capocaccia | H. Møller | P. Grosclaude | P. Carli | T. Aareleid | A. Micheli | A. Verdecchia | T. Matsuda | H Møller | A Micheli | J Faivre | G Gatta | A Verdecchia | M. Santaquilani | P. Roazzi | T Möller | R Capocaccia | P Grosclaude | G Hédelin | M Sant | T Aareleid | M Bielska Lasota | P M Carli | T Matsuda | M Santaquilani | D Lisi | M. Bielska Lasota | D. Lisi | G. Hédelin
[1] M. Coleman,et al. Trends in cancer incidence and mortality. , 1993, IARC scientific publications.
[2] Mike Quinn,et al. Standard cancer patient population for age standardising survival ratios. , 2004, European journal of cancer.
[3] M. Zoli,et al. Surveillance for Hepatocellular Carcinoma in Elderly Italian Patients With Cirrhosis: Effects on Cancer Staging and Patient Survival , 2004, American Journal of Gastroenterology.
[4] J. Aitken,et al. International Trends in Prostate-Cancer Mortality: The Decrease is Continuing and Spreading , 2004, Cancer Causes & Control.
[5] M. Coleman,et al. Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.
[6] E Carrani,et al. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] R. Capocaccia,et al. Electronic availability of EUROCARE-3 data: a tool for further analysis. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] Z Wronkowski,et al. European health systems and cancer care. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] M. Coleman,et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe , 2003, International journal of cancer.
[10] T. MacDonald,et al. Medulloblastoma: Present Concepts of Stratification into Risk Groups , 2003, Pediatric Neurosurgery.
[11] W. Ajiki,et al. Comparison of stomach cancer incidence and survival in four continents. , 2003, European journal of cancer.
[12] F. Bray,et al. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. , 2003, The Lancet. Oncology.
[13] C. Wiggins,et al. Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate. , 2002, Urologic oncology.
[14] Peter H Gann,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.
[15] Paul Russo,et al. Mode of presentation of renal cell carcinoma provides prognostic information. , 2002, Urologic oncology.
[16] C. Faivre-Finn,et al. Colon cancer in France: evidence for improvement in management and survival , 2002, Gut.
[17] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.
[18] M. Sant. Differences in stage and therapy for breast cancer across Europe , 2001, International journal of cancer.
[19] M. Coleman,et al. Cancer survival increases in Europe, but international differences remain wide. , 2001, European journal of cancer.
[20] F. Berrino,et al. Incidence and prevalence of all cancerous diseases in Italy: trends and implications. , 2001, European journal of cancer.
[21] H. Møller. Trends in incidence of testicular cancer and prostate cancer in Denmark , 2001, Human reproduction.
[22] G. Tagliabue,et al. Coding criteria of bladder cancer: effects on estimating survival. , 2001, Epidemiologia e prevenzione.
[23] J. Coebergh,et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study , 2000, Gut.
[24] L. Kiemeney,et al. Gender differences in stage-adjusted bladder cancer survival. , 2000, Urology.
[25] L. Sobin,et al. International Classification of Diseases for Oncology, Third Edition , 2020, Definitions.
[26] J. Faivre,et al. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations , 1999, British Journal of Cancer.
[27] E. Feuer,et al. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.
[28] L. Collette,et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.
[29] A. Engeland,et al. Do morphology and stage explain the inferior lung cancer survival in Denmark? , 1999, The European respiratory journal.
[30] Lawrence D. True,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .
[31] M. Sant,et al. Survival rates for primary malignant brain tumours in Europe. EUROCARE Working Group. , 1998, European journal of cancer.
[32] F. Berrino,et al. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. , 1998, European journal of cancer.
[33] D. Forman,et al. Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. , 1998, European journal of cancer.
[34] P. Muti,et al. The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. , 1998, European journal of cancer.
[35] G. Gatta,et al. Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group. , 1998, European journal of cancer.
[36] G. Hédelin,et al. Improved survival for patients with testicular cancer in Europe since 1978. EUROCARE Working Group. , 1998, European journal of cancer.
[37] F. Berrino,et al. Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. , 1998, European journal of cancer.
[38] J. Redburn,et al. Improving survival of melanoma patients in Europe since 1978. EUROCARE Working Group. , 1998, European journal of cancer.
[39] T. Hakulinen,et al. Variation in survival of adult patients with thyroid cancer in Europe. EUROCARE Working Group. , 1998, European journal of cancer.
[40] Mireille J. M. Broeders,et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .
[41] S. Msika,et al. Population‐based study of diagnosis, treatment and prognosis of gastric cancer , 1997, The British journal of surgery.
[42] T. Liu,et al. Epidemiology of malignant melanoma. , 1996, The Surgical clinics of North America.
[43] B A Miller,et al. The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.
[44] D. Casciato. Manual of Clinical Oncology , 1995 .
[45] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[46] L. Kiemeney,et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. , 1994, European journal of cancer.
[47] M. Tattersall,et al. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] I Persson,et al. The relation between survival and age at diagnosis in breast cancer. , 1986, The New England journal of medicine.
[49] T. Hakulinen,et al. A computer program package for relative survival analysis. , 1985, Computer programs in biomedicine.
[50] T. Hakulinen,et al. Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.
[51] N. Breslow,et al. Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France , 1977, International journal of cancer.
[52] K. Franssila. Prognosis in thyroid carcinoma , 1975, Cancer.
[53] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.